James Kalabus
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 12
- CAR-T cell therapy research 6
- Peptidase Inhibition and Analysis 3
-
- Protease and Inhibitor Mechanisms 3
- MicroRNA in disease regulation 2
- Co-authors
- Javier G. Blanco (7 shared papers)Ai‐Ming Yu (1 shared paper)Zihua Hu (1 shared paper)Andrew E. Bruno (1 shared paper)Yuzhuo Pan (1 shared paper)Vanessa González-Covarrubias (2 shared papers)Qiuying Cheng (4 shared papers)Thierry Façon (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Pharmaceutical Research (2 papers)Drug Metabolism and Disposition (2 papers)Clinical Cancer Research (1 paper)Pharmacogenomics (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
James Kalabus
21 papers receiving 646 citations
James Kalabus's Hit Papers
Peers
Comparison fields: 5 of 76
- Hematology 223
- Oncology 296
- Cancer Research 121
- Radiology, Nuclear Medicine and Imaging 130
- Immunology 100
Countries citing papers authored by James Kalabus
This map shows the geographic impact of James Kalabus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Kalabus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Kalabus more than expected).
Fields of papers citing papers by James Kalabus
This network shows the impact of papers produced by James Kalabus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Kalabus. The network helps show where James Kalabus may publish in the future.
Co-authors
The 25 scholars most cited alongside James Kalabus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma Hit paper breakdown → | 2020 | 233 |
| 2 | 2012 | 142 | |
| 3 | 2019 | 44 | |
| 4 | 2008 | 32 | |
| 5 | 2008 | 30 | |
| 6 | 2023 | 28 | |
| 7 | 2010 | 23 | |
| 8 | 2012 | 22 | |
| 9 | 2019 | 20 | |
| 10 | 2014 | 17 | |
| 11 | 2011 | 15 | |
| 12 | 2020 | 15 | |
| 13 | 2012 | 14 | |
| 14 | 2020 | 9 | |
| 15 | 2016 | 7 | |
| 16 | 2024 | 5 | |
| 17 | 2021 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2019 | 1 |
About James Kalabus
James Kalabus is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 22 papers that have together received 661 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Aldose Reductase and Taurine (4 papers), Multiple Myeloma Research and Treatments (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Protease and Inhibitor Mechanisms (3 papers), Peptidase Inhibition and Analysis (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Hematology (223 citations), Oncology (296 citations), Cancer Research (121 citations), Radiology, Nuclear Medicine and Imaging (130 citations) and Immunology (100 citations). James Kalabus has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Javier G. Blanco, Ai‐Ming Yu, Zihua Hu, Andrew E. Bruno, Yuzhuo Pan, Vanessa González-Covarrubias, Qiuying Cheng, Thierry Façon, Erik Rasmussen and Philippe Moreau. Their work appears in journals such as Journal of Clinical Oncology, Pharmaceutical Research, Drug Metabolism and Disposition, Clinical Cancer Research and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.